National Association of Pharmacy Regulatory Authorities
National Association of Pharmacy Regulatory Authorities

Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Reset
Print Friendly Export to CSV
Drug Name Comment Schedule Date
Famciclovir and its saltsF1 I SEP / 98
Famotidine and its saltsF1 except when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn I FEB / 07
Famotidine and its salts. when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing more than 600 mg of famotidine III MAY / 08
Famotidine and its salts.. when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing no more than 600 mg of famotidine U FEB / 07
Febuxostat or its salts or derivativesPDL I DEC / 13
Felodipine and its saltsF1 I SEP / 98
Fenetylline and any salt thereofC5 I JAN / 03
Fenfluramine or its saltsPDL

including but not limited to dexfenfluramine

 I DEC / 13
FenofibrateF1 I SEP / 98
Fenoprofen and its saltsF1 I SEP / 98
Fenoterol and its saltsF1 I SEP / 98
FenproporexTS I JUN / 02
FentanylN I JUN / 02
Fexofenadine hydrochloride in products marketed for adult use (12 years and older) U APR / 07
Fexofenadine hydrochloride. in products marketed for paediatric use (under 12 years of age) III APR / 07
Fibrin II SEP / 98
Fibrinolysin II SEP / 98
FilgrastimF1 I SEP / 98
Finafloxacin or its salts or its derivativesPDL I AUG / 16
FinasterideF1 I SEP / 98
Fingolimod or its salts or derivativesPDL

including but not limited to fingolimod hydrochloride

 I DEC / 13
FirocoxibPDL I DEC / 13
Flavoxate and its saltsF1 I SEP / 98
Flecainide and its saltsF1 I SEP / 98
Fleroxacin and its salts and derivativesF1 I SEP / 98
Flibanserin or its saltsPDL I MAY / 18
FloctafenineF1 I SEP / 98
Florfenicol and its derivativesF1 I SEP / 98
FluconazoleF1 except when sold in a concentration of 150 mg per oral dosage unit and indicated for the treatment of vaginal candidiasis I MAR / 10
Fluconazole when sold in a concentration of 150 mg per oral dosage unit and indicated for the treatment of vaginal candidiasis, in package sizes containing no more than 150 mg of fluconazole III MAR / 10
FlucytosineF1 I SEP / 98
Fludarabine and its salts and derivativesF1 I SEP / 98
FludiazepamTS I JUN / 02
Flumazenil I SEP / 98
Flunarizine and its saltsF1 I SEP / 98
FlunitrazepamTS I JUN / 02
Flunixin and its salts and derivativesF1 I SEP / 98
Fluoride or its salts (see sodium fluoride)

in solid oral dosage forms containing more than 1 mg of fluoride ion

 I SEP / 98
Fluoride or its salts (see sodium fluoride).

in oral preparations containing 1 mg or less of fluoride ion per dosage unit

 III SEP / 98
Fluorouracil or its derivativesPDL

including but not limited to capecitabine, tegafur

 I DEC / 13
Fluoxetine and its saltsF1 I SEP / 98
FluoxymesteroneC3 I JUN / 02
Flupentixol and its salts and derivativesF1 I SEP / 98
Fluphenazine and its saltsF1 I SEP / 98
FluralanerPDL I JUL / 14
Flurazepam and its saltsTS I SEP / 98
Flurbiprofen and its saltsF1 I SEP / 98
FluspirileneF1 I SEP / 98
FlutamideF1 I SEP / 98
Fluticasone propionate when sold for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 18 years of age and older, in package sizes containing no more than 120 metered sprays III AUG / 16
Fluticasone propionate when sold for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 18 years of age and older, in package sizes containing more than 120 metered sprays II AUG / 16
Fluvastatin and its salts and derivativesF1 I SEP / 98
Fluvoxamine and its saltsF1 I SEP / 98
Folic AcidF2 I DEC / 99
Folic acidF1 in preparations containing more than 1 mg of folic acid per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 1.0 mg folic acid I SEP / 98
Follicle stimulating hormonePDL

including but not limited to: follitropin alpha, follitropin beta, follitropin delta

 I DEC / 13
Fomepizole and its saltsF1 I JUL / 03
Fondaparinux sodiumF1 I JUN / 06
FormeboloneC3 I SEP / 98
Formestane and derivativesF1 I SEP / 98
Formoterol and its saltsF1 I JUN / 06
Foscarnet sodiumF1 I SEP / 98
Fosfomycin and its saltsF1 I SEP / 99
Fosinopril and its saltsF1 I SEP / 98
Fosphenytoin and its saltsF1 I SEP / 98
Fractar III SEP / 98
Framycetin and its salts and derivativesF2 I SEP / 98
Frovatriptan and its saltsF1 I FEB / 07
FulvestrantF1 I SEP / 06
Furaltadone and its saltsF2 I SEP / 98
FurazabolC3 I SEP / 98
Furazolidone and its saltsF2 I SEP / 98
FurethidineN I JUN / 02
FurosemideF2 I SEP / 98
Fusidic acid and its saltsF1 I SEP / 98

75 result(s)

Print Friendly Export to CSV

Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled